Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Philibert

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature Clinical Practice. Nephrology|August 30, 2008
Remission of proteinuria in primary glomerulonephritis: we know the goal but do we know the price?David Philibert, Daniel Cattran
Seminars in Nephrology|January 29, 2008
Clinicopathologic correlation in IgA nephropathyDavid Philibert, Daniel Cattran, Terence Cook
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 3, 2005
In vivo quantification of central venous catheter leakDavid Philibert, Simon Desmeules, Juan Friede, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 28, 2007
Incidence and severity of early electrolyte abnormalities following autologous haematopoietic stem cell transplantationDavid Philibert, Simon Desmeules, Alain Filion, et al.
Kidney Medicine|July 7, 2023
Pembrolizumab-Induced Anti-GBM Glomerulonephritis: A Case ReportNidal El Yamani, Gabrielle Cote, Julie Riopel, et al.
Rheumatology (Oxford, England)|December 24, 2013
The interpretation of repeat renal biopsies in patients with lupus nephritisMichael McRae, Mathieu Rousseau-Gagnon, David Philibert, et al.
Canadian Journal of Kidney Health and Disease|February 13, 2020
Clinical Characteristics and Outcome of Canadian Patients Diagnosed With Atypical Hemolytic Uremic SyndromeAnne-Laure Lapeyraque, Martin Bitzan, Imad Al-Dakkak, et al.
Nephron|June 20, 2015
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)Fernando C Fervenza, Pietro A Canetta, Sean J Barbour, et al.
The New England Journal of Medicine|July 4, 2019
Rituximab or Cyclosporine in the Treatment of Membranous NephropathyFernando C Fervenza, Gerald B Appel, Sean J Barbour, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature Clinical Practice. Nephrology|August 30, 2008
Remission of proteinuria in primary glomerulonephritis: we know the goal but do we know the price?David Philibert, Daniel Cattran
Seminars in Nephrology|January 29, 2008
Clinicopathologic correlation in IgA nephropathyDavid Philibert, Daniel Cattran, Terence Cook
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 3, 2005
In vivo quantification of central venous catheter leakDavid Philibert, Simon Desmeules, Juan Friede, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 28, 2007
Incidence and severity of early electrolyte abnormalities following autologous haematopoietic stem cell transplantationDavid Philibert, Simon Desmeules, Alain Filion, et al.
Kidney Medicine|July 7, 2023
Pembrolizumab-Induced Anti-GBM Glomerulonephritis: A Case ReportNidal El Yamani, Gabrielle Cote, Julie Riopel, et al.
Rheumatology (Oxford, England)|December 24, 2013
The interpretation of repeat renal biopsies in patients with lupus nephritisMichael McRae, Mathieu Rousseau-Gagnon, David Philibert, et al.
Canadian Journal of Kidney Health and Disease|February 13, 2020
Clinical Characteristics and Outcome of Canadian Patients Diagnosed With Atypical Hemolytic Uremic SyndromeAnne-Laure Lapeyraque, Martin Bitzan, Imad Al-Dakkak, et al.
Nephron|June 20, 2015
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)Fernando C Fervenza, Pietro A Canetta, Sean J Barbour, et al.
The New England Journal of Medicine|July 4, 2019
Rituximab or Cyclosporine in the Treatment of Membranous NephropathyFernando C Fervenza, Gerald B Appel, Sean J Barbour, et al.
Pageof 1